Evidence map›Paper›PMID 36872317›Full record

ArticleVirology journal2023

A full genome tiling array enhanced the inspection and quarantine of SARS-CoV-2.

Runzi Qi, Gang Wang, Xu Wang, Cheng Li, Lei Huang, Weixi Xiao, Bing Shao, Chunya Zhou, Xun Ding, Feng Li and 1 more

Abstract read
In one paragraph

Article in Virology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Runzi Qi *Hangzhou Xiaoshan Airport Customs of the People's Republic of China, Hangzhou, 311241, China. 724859571@qq.com.
Gang Wang *Hangzhou International Travel Healthcare Center, Hangzhou, 310061, China.
Xu WangCentrillion Technology (Hangzhou) Co., Ltd, Hangzhou, 310053, China.
Cheng LiHangzhou Customs Logistics Management Center, Hangzhou, 310005, China.
Lei HuangZhoushan International Travel Healthcare Center Clinic, Zhoushan, 316004, China.
Weixi XiaoCentrillion Technology (Hangzhou) Co., Ltd, Hangzhou, 310053, China.
Bing ShaoCentrillion Technology (Hangzhou) Co., Ltd, Hangzhou, 310053, China.
Chunya ZhouHangzhou Xiaoshan Airport Customs of the People's Republic of China, Hangzhou, 311241, China.
Xun DingCentrillion Technologies, Palo Alto, CA, 94303, USA.
Feng LiCentrillion Technology (Hangzhou) Co., Ltd, Hangzhou, 310053, China.
Wei ZhouCentrillion Technologies, Palo Alto, CA, 94303, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the worldwide spreading epidemic of SARS-CoV-2, quick inspection and quarantine of passengers for SARS-CoV-2 infection are essential for controlling the spread of SARS-CoV-2, especially the cross-border transmission. This study reports a SARS-CoV-2 genome sequencing method based on a re-sequencing tiling array successfully used in border inspection and quarantine. The tiling array chip has four cores, with one core of 240,000 probes dedicated to the whole genome sequencing of the SAR-CoV-2 genome. The assay protocol has been improved to reduce the detection time to within one day and can detect 96 samples in parallel. The detection accuracy has been validated. This fast and simple procedure is also of low cost and high accuracy, and it is particularly suitable for the rapid tracking of viral genetic variants in custom inspection applications. Combining these properties means this method has significant application potential in the clinical investigation and quarantine of SARS-CoV-2. We used this SARS-CoV-2 genome re-sequencing tiling array to inspect and quarantine China's entry and exit ports in the Zhejiang Province. From November 2020 to January 2022, we observed the gradual shift of SARS-CoV-2 variants from the D614G type to the Delta Variant, and then to the dominance of the Omicron variant recently, consistently with the global emergency pattern of the new SARS-CoV-2 variant.

Indexed as

COVID-19SARS-CoV-2Chromosome MappingHumansQuarantineFull genome tiling arrayInspection and quarantinePortsSARS-CoV-2Variation

Identifiers

PMID36872317
PMCPMC9985699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.